These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 7473180

  • 21. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 22. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL, Lajiness ME, Huff RM.
    Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
    [Abstract] [Full Text] [Related]

  • 23. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallager DW.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [Abstract] [Full Text] [Related]

  • 24. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J, Maeno K, Hidaka K, Nakato K, Matsumoto M, Tada S, Hattori H, Sakamoto S, Tsukamoto S, Usuda S, Mase T.
    J Med Chem; 1996 Jul 05; 39(14):2764-72. PubMed ID: 8709107
    [Abstract] [Full Text] [Related]

  • 25. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

  • 26. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 10; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 27. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.
    Mol Pharmacol; 1996 Dec 10; 50(6):1658-64. PubMed ID: 8967990
    [Abstract] [Full Text] [Related]

  • 28. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ.
    J Pharmacol Exp Ther; 1995 Jun 10; 273(3):1032-46. PubMed ID: 7791073
    [Abstract] [Full Text] [Related]

  • 29. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
    Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB.
    J Pharmacol Exp Ther; 1994 Feb 10; 268(2):935-42. PubMed ID: 8114008
    [Abstract] [Full Text] [Related]

  • 30. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V.
    J Pharmacol Exp Ther; 1994 Jan 10; 268(1):337-52. PubMed ID: 8301575
    [Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S, Chaki S, Yoshikawa R, Suzuki Y, Ogawa S, Imagawa Y, Kawashima N, Ikeda Y, Kumagai T, Nakazato A, Nagamine M, Tomisawa K.
    J Pharmacol Exp Ther; 1997 Jul 10; 282(1):56-63. PubMed ID: 9223539
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE.
    J Pharmacol Exp Ther; 1996 Dec 10; 279(3):1392-403. PubMed ID: 8968364
    [Abstract] [Full Text] [Related]

  • 33. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM, Brewster WK, Cook LL, Nichols DE, Mailman RB.
    J Pharmacol Exp Ther; 1992 Jul 10; 262(1):383-93. PubMed ID: 1352553
    [Abstract] [Full Text] [Related]

  • 34. Role of dopamine D3 receptors in thermoregulation: a reappraisal.
    Perachon S, Betancur C, Pilon C, Rostène W, Schwartz JC, Sokoloff P.
    Neuroreport; 2000 Jan 17; 11(1):221-5. PubMed ID: 10683862
    [Abstract] [Full Text] [Related]

  • 35. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
    Varty GB, Higgins GA.
    Behav Pharmacol; 1998 Sep 17; 9(5-6):445-55. PubMed ID: 9832930
    [Abstract] [Full Text] [Related]

  • 36. Regulation of dopamine D2 receptors in a novel cell line (SUP1).
    Ivins KJ, Luedtke RR, Artymyshyn RP, Molinoff PB.
    Mol Pharmacol; 1991 Apr 17; 39(4):531-9. PubMed ID: 1708089
    [Abstract] [Full Text] [Related]

  • 37. The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats.
    Millan MJ, Gressier H, Brocco M.
    Eur J Pharmacol; 1997 Mar 05; 321(3):R7-9. PubMed ID: 9085054
    [Abstract] [Full Text] [Related]

  • 38. Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo.
    Lejeune F, Millan MJ.
    Eur J Pharmacol; 1995 Mar 14; 275(3):R7-9. PubMed ID: 7768288
    [Abstract] [Full Text] [Related]

  • 39. Dopamine D2-like receptor agonists induce penile erection in male rats: differential role of D2, D3 and D4 receptors in the paraventricular nucleus of the hypothalamus.
    Sanna F, Succu S, Hübner H, Gmeiner P, Argiolas A, Melis MR.
    Behav Brain Res; 2011 Nov 20; 225(1):169-76. PubMed ID: 21784104
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
    Coldwell MC, Boyfield I, Brown AM, Stemp G, Middlemiss DN.
    Br J Pharmacol; 1999 Jul 20; 127(5):1135-44. PubMed ID: 10455259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.